And the beat goes onis a refrain that kept rolling through my head after attending the symposium Tuesday hosted by the Womens Institute for a Secure Retirement (WISER) in Washington, D.C. The topic: retirement solutions for women.
KB Home (KBH) doesn’t report earnings until after the close, but the market isn’t taking any chances. Its shares–as well as those of homebuilders like PulteGroup (PHM) and DR Horton (DHI)–are getting whacked today following disappointing housing-starts data, and Lennar’s (LEN) below-consensus order growth.
There’s a saying in the tech world: If you’re not paying for the product, you are the product.
That means if you’re using a free app or a service, chances are it’s using your information to make money. For instance, Google (GOOG) and Facebook (FB, Tech30) use data like your location and interests to distribute targeted advertising.
When the S&P 500 hit a new all-time high on Monday, investors on the sideline were left with a choice worthy of Hamlet: To buy or not to buy? FBN’s JC OHara urges patience:
With the uptick in new bottom up highs as well as a new overall high for the S&P 500, can we be safe to assume the Bulls are back in charge? Well, we remain comfortable neutral for the time being....More>>>
When Melinda Gates turned 50, she decided to dedicate the rest of her life to empowering women and girls — and fighting to advance opportunities for them.
At that point, the co-chair of the Bill and Melinda Gates Foundation, the world’s largest private charity, had been traveling the world for over 15 years. The foundation, which mainly focuses on eradicating extreme poverty and....More>>>
The Restasis patent battle between Mylan (MYL) and Allergan is heating up. Mylan heavily criticized Allergan for partnering with St. Regis Mohawks to protect the patents, calling the arrangement “desperate”:
Mylan has had no shortage of critics over the last year as it suffered from a stinging EpiPen pricing scandal. Now, the generic giant is....More>>>
The performance of Exxon Mobil Corporation (NYSE:XOM) stock over the past decade appears rather unimpressive. Over the past ten years, including dividends, XOM stock has returned 49% — total. That’s an average return of just 4% per year, well below the S&P 500. Over the past five years, the news is even worse. Exxon Mobil stock has declined over that period. Including dividends,....More>>>
For months, strategists warned that high valuations in the U.S. could leave stocks vulnerable to a correction. But valuations seemed to have had little hand in guiding investors during this year’s steep declines across global markets.
Equity markets that were relatively more “expensive”those with higher valuationsdidn’t suffer any more than their “cheaper”....More>>>
According to a report by Research Beam, the Global Data Center Market is estimated to grow at 10.7% annually through the period 2016 to 2020. The growth in the industry is attributed to the increasing demand among organizations to move to virtualization and automation while demanding higher operational efficiency. London-based Global Switch (SWITCH) is a Billion-Dollar Unicorn player in the data....More>>>
This week I have selected 8 breakout stocks from the following sectors: 2 healthcare, 2 industrial goods, 1 basic materials, 1 services and 2 technology. Charts for each stock are at the end of the article.
The new selections of positive momentum stocks for this week include:
On Friday, small cap biotechArrowhead Pharmaceuticals (NASDAQ: ARWR) jumped 18.28% after hosting an investor & analyst R&D day to introduce its proprietary Targeted RNAi Molecule (TRiMTM) platform and to review its pipeline of RNAi therapeutic candidates. Arrowhead Pharmaceuticals develop